Cécile Alanio

Cécile Alanio

Auto-generated profile, based on publicly available information

Cécile Alanio

Laboratoire de Biologie Clinique, Hopital Foch, Suresnes - France ; Universite Paris Cite, INSERM, PARCC, Paris - France

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2020 in Science
Verified
Journal Article
Open access
PDF file
DMDivij Mathew
Divij Mathew
JGJosephine R. Giles
Josephine R. Giles
ABAmy E. Baxter
Amy E. Baxter
DODerek A. Oldridge
Derek A. Oldridge
AGAllison R. Greenplate
Allison R. Greenplate
AVAshley N. Vanderbeck
Ashley N. Vanderbeck
Immune profiling of COVID-19 patients: Coronavirus disease 2019 (COVID-19) has affected millions of people globally, yet how the human immune system responds to and influences COVID-19 severity remains unclear. Mathew et al. present a comprehensive atlas of immune modulation associated with COVID-19. They performed high-dimensional flow cytometry of hospitalized COVID-19 patients and found three prominent and distinct immunotypes that are related to disease severity and clinical parameters. Arunachalam et al. report a systems biology approach to assess the immune system of COVID-19 patients with mild-to-severe disease. These studies provide a compendium of immune cell information and roadmaps for potential therapeutic interventions. Science , this issue p. eabc8511 , p. 1210

2 February 2022 in Nature
Verified
Journal Article
Closed access
PDF file
Jan Joseph MelenhorstJan Joseph Melenhorst
Jan Joseph Melenhorst
GCGregory M. Chen
Gregory M. Chen
MWMeng Wang
Meng Wang
DPDavid L. Porter
David L. Porter
CCChangya Chen
Changya Chen
CJCarl H. June
Carl H. June

1 January 2013 in Cancer Research
Verified
Journal Article
Closed access
CBCécile Badoual
Cécile Badoual
SHStéphane Hans
Stéphane Hans
NMNathalie Merillon
Nathalie Merillon
CRCordélia Van Ryswick
Cordélia Van Ryswick
PRPatrice Ravel
Patrice Ravel
Eric TartourEric Tartour
Eric Tartour
Head and neck cancers positive for human papillomavirus (HPV) have a more favorable clinical outcome than HPV-negative cancers, but it is unknown why this is the case. We hypothesized that prognosis was affected by intrinsic features of HPV-infected tumor cells or differences in host immune response. In this study, we focused on a comparison of regulatory Foxp3+ T cells and programmed death-1 (PD-1)+ T cells in the microenvironment of tumors that were positive or negative for HPV, in two groups that were matched for various clinical and biologic parameters. HPV-positive head and neck cancers were more heavily infiltrated by regulatory T cells and PD-1+ T cells and the levels of PD-1+ cells were positively correlated with a favorable clinical outcome. In explaining this paradoxical result, we showed that these PD-1+ T cells expressed activation markers and were functional after blockade of the PD-1–PD-L1 axis in vitro. Approximately 50% of PD-1+ tumor-infiltrating T cells lacked Tim-3 expression and may indeed represent activated T cells. In mice, administration of a cancer vaccine increased PD-1 on T cells with concomitant tumor regression. In this setting, PD-1 blockade synergized with vaccine in eliciting antitumor efficacy. Our findings prompt a need to revisit the significance of PD-1–infiltrating T cells in cancer, where we suggest that PD-1 detection may reflect a previous immune response against tumors that might be reactivated by PD-1/PD-L1 blockade. Cancer Res; 73(1); 128–38. ©2012 AACR.

20 May 2021 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
EBErin M. Bange
Erin M. Bange
NHNicholas A. Han
Nicholas A. Han
PWPaul Wileyto
Paul Wileyto
JKJustin Y. Kim
Justin Y. Kim
SGSigrid Gouma
Sigrid Gouma
AHAlexander C. Huang
Alexander C. Huang

23 February 2018 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
TCThe Milieu Intérieur Consortium
The Milieu Intérieur Consortium
EPEtienne Patin
Etienne Patin
MHMilena Hasan
Milena Hasan
JBJacob Bergstedt
Jacob Bergstedt
VRVincent Rouilly
Vincent Rouilly
MAMatthew L. Albert
Matthew L. Albert

12 January 2024 in Nature Cancer
Verified
Journal Article
Closed access
PDF file
SBStephen Joseph Bagley
Stephen Joseph Bagley
ZBZev A. Binder
Zev A. Binder
LLLamia Lamrani
Lamia Lamrani
EMEliana Marinari
Eliana Marinari
ADArati S. Desai
Arati S. Desai
DODonald M. O’rOurke
Donald M. O’rOurke